Add to ORKGBettina K Andreassen,1 Helga H Hektoen,1 Karol Axcrona,2 Hilde Langseth,1 Jo S Stenehjem,1 Trude E Robsahm1 1Department of Research, Cancer Registry of Norway, Oslo, Norway; 2Department of Urology, Akershus University Hospital, Lørenskog, NorwayCorrespondence: Helga H Hektoen Email Helga.Helseth.Hektoen@kreftregisteret.no View the original paper by Dr Hektoen and colleagues This is in response to the Letter to the Edito
The enumeration of circulating tumor cells (CTCs) holds great promise for clinical decision making. ...
Bladder cancer is one of the costliest cancers and understanding the nuances of appropriate imaging ...
Abstract: Background: Bromodomain 4 (BRD4) protein is a double bromodomain-containing protein that b...
Reza Rastmanesh1,2 1The Nutrition Society, London, UK; 2The American Physical Society, College Park,...
The recent study by Mondul and colleagues failed to find a significant correlation between prediagno...
Giovannucci enquires whether intervention studies were long enough to allow full expression of healt...
Rarer Cancers failed to find a reduced risk of cancer in-cidence associated with higher levels (>...
We thank Raimondi et al. for their alternative interpretation of our results on the prognostic value...
Abstract This article is a commentary on an article published in World Journal of Surgical Oncology ...
<b><i>Background/Aims: </i></b>Vitamin D status in relation to bladder carcinoma risk was still inco...
Item does not contain fulltextWe previously reported that lower post-diagnostic circulating 25-hydro...
Aim: To establish independent prognostic factors on a chromosomal basis in superficial bladder cance...
We thank Kiemeney for his interest and commentary [1] on our paper [2]. He discusses the limitations...
We are thankful for the elaborate editorial comment. In the present study, we enrolled 13 young fema...
Comment on: Stolarz-Skrzypek K, Kuznetsova T, Thijs L, Tikhonoff V, Seidlerová J, Richart T, Jin Y, ...
The enumeration of circulating tumor cells (CTCs) holds great promise for clinical decision making. ...
Bladder cancer is one of the costliest cancers and understanding the nuances of appropriate imaging ...
Abstract: Background: Bromodomain 4 (BRD4) protein is a double bromodomain-containing protein that b...
Reza Rastmanesh1,2 1The Nutrition Society, London, UK; 2The American Physical Society, College Park,...
The recent study by Mondul and colleagues failed to find a significant correlation between prediagno...
Giovannucci enquires whether intervention studies were long enough to allow full expression of healt...
Rarer Cancers failed to find a reduced risk of cancer in-cidence associated with higher levels (>...
We thank Raimondi et al. for their alternative interpretation of our results on the prognostic value...
Abstract This article is a commentary on an article published in World Journal of Surgical Oncology ...
<b><i>Background/Aims: </i></b>Vitamin D status in relation to bladder carcinoma risk was still inco...
Item does not contain fulltextWe previously reported that lower post-diagnostic circulating 25-hydro...
Aim: To establish independent prognostic factors on a chromosomal basis in superficial bladder cance...
We thank Kiemeney for his interest and commentary [1] on our paper [2]. He discusses the limitations...
We are thankful for the elaborate editorial comment. In the present study, we enrolled 13 young fema...
Comment on: Stolarz-Skrzypek K, Kuznetsova T, Thijs L, Tikhonoff V, Seidlerová J, Richart T, Jin Y, ...
The enumeration of circulating tumor cells (CTCs) holds great promise for clinical decision making. ...
Bladder cancer is one of the costliest cancers and understanding the nuances of appropriate imaging ...
Abstract: Background: Bromodomain 4 (BRD4) protein is a double bromodomain-containing protein that b...